Skip to main content

Research Repository

Advanced Search

Impact on survival of modelling increased surgical resection rates in patients with non-small-cell lung cancer and cardiovascular comorbidities: a VICORI study

Welch, Catherine A.; Sweeting, Michael J.; Lambert, Paul C.; Rutherford, Mark J.; Jack, Ruth H.; West, Douglas; Adlam, David; Peake, Michael

Impact on survival of modelling increased surgical resection rates in patients with non-small-cell lung cancer and cardiovascular comorbidities: a VICORI study Thumbnail


Authors

Catherine A. Welch

Michael J. Sweeting

Paul C. Lambert

Mark J. Rutherford

RUTH JACK Ruth.Jack@nottingham.ac.uk
Senior Research Fellow

Douglas West

David Adlam

Michael Peake



Abstract

©2020, The Author(s). Background: The impact of cardiovascular disease (CVD) comorbidity on resection rates and survival for patients with early-stage non-small-cell lung cancer (NSCLC) is unclear. We explored if CVD comorbidity explained surgical resection rate variation and the impact on survival if resection rates increased. Methods: Cancer registry data consisted of English patients diagnosed with NSCLC from 2012 to 2016. Linked hospital records identified CVD comorbidities. We investigated resection rate variation by geographical region using funnel plots; resection and death rates using time-to-event analysis. We modelled an increased propensity for resection in regions with the lowest resection rates and estimated survival change. Results: Among 57,373 patients with Stage 1−3A NSCLC, resection rates varied considerably between regions. Patients with CVD comorbidity had lower resection rates and higher mortality rates. CVD comorbidity explained only 1.9% of the variation in resection rates. For every 100 CVD comorbid patients, increasing resection in regions with the lowest rates from 24 to 44% would result in 16 more patients resected and alive after 1 year and two fewer deaths overall. Conclusions: Variation in regional resection rate is not explained by CVD comorbidities. Increasing resection in patients with CVD comorbidity to the levels of the highest resecting region would increase 1-year survival.

Journal Article Type Article
Acceptance Date Apr 16, 2020
Online Publication Date May 11, 2020
Publication Date Aug 4, 2020
Deposit Date May 11, 2020
Publicly Available Date May 12, 2020
Journal British Journal of Cancer
Print ISSN 0007-0920
Electronic ISSN 1532-1827
Publisher Cancer Research UK
Peer Reviewed Peer Reviewed
Volume 123
Pages 471–479
DOI https://doi.org/10.1038/s41416-020-0869-8
Keywords Cancer Research; Oncology
Public URL https://nottingham-repository.worktribe.com/output/4418833
Publisher URL https://www.nature.com/articles/s41416-020-0869-8